The ASCO Post
@ASCOPost
News and views from the world of clinical oncology and hematology
ID:96994334
http://WWW.ASCOPOST.COM 15-12-2009 14:48:51
33,2K Tweets
60,9K Followers
4,7K Following
Bispecific Antibody Plus Chemotherapy Improves Survival in Patients With Gastric or Gastroesophageal Junction Cancer ascopost.com/issues/may-10-… #stcsm #gastriccancer #GEJcancer #oncology
Anant Madabhushi, PhD, & Jame Abraham, MD, FACP, on AI in Cancer Care: Embrace the Change ascopost.com/issues/may-10-… Anant Madabhushi Jame Abraham, MD, FACP #cancer #oncology #AI
Chemical-Related Epigenetic Modifications May Increase Risk of Prostate Cancer Among Firefighters ascopost.com/news/may-2024/… #pcsm #prostatecancer #oncology #epigenetics #firefighters
🙌 It was great to participate in the educational case-based video series w/ outstanding experts Wilmot Cancer Institute Carla Casulo, MD & City of Hope L. Elizabeth Budde, M.D., Ph.D. for the ASCO ASCOPost on treatment options for relapsed/refractory follicular #lymphoma (SEE: ascopost.com/video-roundtab…).…
Newly Identified Biomarkers May Improve Diagnosis and Treatment of RCC Subtypes ascopost.com/news/may-2024/… #kcsm #kidneycancer #RCC #biomarkers #oncology
Historical Community Outreach and Engagement Efforts at NCI-Designated Cancer Centers ascopost.com/news/may-2024/… #oncology National Cancer Institute #cancercenters
Addition of Durvalumab to Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer: PROs in TOPAZ-1 ascopost.com/news/may-2024/… #hpbcsm #bileductcancer #cholangiocarcinoma #oncology #immunotherapy
Bavituximab Plus Pembrolizumab for Patients With Hepatocellular Carcinoma ascopost.com/news/may-2024/… #hpbcsm #livercancer #HCC #oncology #immunotherapy